Lichen International Limited
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $809.0K | $0 | $0 | $33.8M | $34.3M | $30.7M |
| Cost of Revenue | $15.4M | $15.8M | $15.4M | $13.6M | $13.8M | $11.8M |
| Gross Profit | $9.1M | $25.7M | $24.3M | $20.2M | $20.5M | $18.8M |
| Gross Margin | 1,129.4% | — | — | 59.7% | 59.7% | 61.4% |
| Operating Expenses | ||||||
| Research & Development | — | — | — | — | — | — |
| SG&A Expense | $12.9M | $17.7M | $8.9M | $7.4M | $7.2M | $8.5M |
| Operating Income | $-18.1M | $-4.6M | $12.3M | $10.6M | $11.3M | $8.8M |
| Operating Margin | -2,233.5% | — | — | 31.5% | 32.9% | 28.7% |
| Interest Expense | — | — | — | — | — | — |
| Pretax Income | $-21.8M | $-4.2M | $11.6M | $10.7M | $11.5M | $9.0M |
| Income Tax Expense | $0 | $1.9M | $3.3M | $2.9M | $3.1M | $2.6M |
| Net Income | $-22.0M | $-6.1M | $8.3M | $7.8M | $8.5M | $6.4M |
| Net Margin | -2,714.7% | — | — | 23.1% | 24.7% | 20.9% |
| EPS (Basic) | $-4.11 | $-1.16 | $2.13 | $2.32 | $0.01 | $0.01 |
| EPS (Diluted) | $-4.11 | $-1.16 | $2.13 | $2.32 | $0.01 | $0.01 |
| Shares Outstanding (Basic) | 5.3M | 5.3M | 782.2M | 675.0M | 675.0M | 675.0M |
| Shares Outstanding (Diluted) | 5.3M | 5.3M | 782.2M | 675.0M | 675.0M | 675.0M |
| Dividends Per Share | — | — | — | — | — | — |